Enhancement of bovine growth hormone activity by antibodies against growth hormone peptides.
The biological activity of growth hormones can be enhanced by complexing with monoclonal antibodies of appropriate specificity. In order to define the regions associated with the phenomenon, site-directed antisera to ovine GH (oGH) were prepared by vaccination of sheep with synthetic peptides. Peptides from six distinct regions of the oGH molecule raised antibodies which recognized the hormone in solid-phase radioimmunoassay; however, only one peptide elicited high-affinity antibody as determined by liquid-phase assay. This peptide, corresponding to amino acid sequence 35-53, resulted in circulating hormone antibody in the majority of vaccinated sheep. Immunoglobulin prepared from the serum of immunized animals produced an enhancement of the somatotrophic activity of exogenously administered GH in dwarf mice as determined by the incorporation of [35S]sulphate into costal cartilage. The identification of an antigenic peptide sequence from oGH/bovine GH which elicits enhancing antisera, raises the possibility of a growth-promotion vaccine.
Bomford
R
R
Wellcome Research Laboratories, Beckenham, Kent.
Aston
R
R
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000502:physiology*; D000918:Antibody Specificity / Q000502:physiology; D002356:Cartilage / Q000187:drug effects / Q000378:metabolism; D002417:Cattle; D013006:Growth Hormone / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D051379:Mice; D008817:Mice, Mutant Strains; D010455:Peptides / Q000276:immunology*; D012756:Sheep
D000911:Antibodies, Monoclonal; D010455:Peptides; D013006:Growth Hormone